Andreas Pahl

Andreas Pahl

Chief Executive Officer at
Heidelberg Pharma Research GmbH
Health Technology
Consumer Services
Commercial Services

Profile

Andreas Pahl is Chief Executive Officer at Simris Biologics GmbH since 2026 and Managing Director at Heidelberg Pharma Research GmbH since 2012.
Former roles include Chief Executive Officer at Heidelberg Pharma AG from 2024 to 2025, Head-Late Pharmacology at Takeda Pharmaceutical Co., Ltd., Professor-Pharmacology & Toxicology at Friedrich-Alexander University of Erlangen-Nuremberg, Professor at Technical University of Berlin, Chief Scientific Officer at Heidelberg Pharma AG, Head-Late Pharmacology at Nycomed GmbH, and Member-Supervisory Board at Emergence Therapeutics AG.
Education includes undergraduate studies at Humboldt-Universität zu Berlin.

Andreas Pahl active positions

CompaniesPositionStart
Chief Executive Officer 2024-01-31
Chief Executive Officer 2026-07-14

Former positions of Andreas Pahl

CompaniesPositionEnd
HEIDELBERG PHARMA AG Chief Executive Officer 2025-11-23
Corporate Officer/Principal -
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal -
Director/Board Member -
Corporate Officer/Principal -
See the detail of Andreas Pahl's experience

Training of Andreas Pahl

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

20

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Commercial Services

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!